Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bentsur Ron
Relationship:   Chairman & CEO, Direct...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   4,188,470    

Indirect Shares

   0      
Direct Value   $52,464    

Indirect Value

   $0      
Total Shares   4,188,470      
Total Value   $52,464      


Keryx Biopharmaceuticals Inc $0 XTL Biopharmaceuticals Ltd $52,464 Beyond Air Ord Shs $0 Nuvectis Pharma, Inc. $0 Keryx Biopharmaceuticals Inc $0 XTL Biopharmaceuticals Ltd $52,464 Beyond Air Ord Shs $0 Nuvectis Pharma, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Keryx Biopharmaceuticals Inc KERX Chief Executive Office... 2015-04-06 777,209 0    Premium*  
            XTL Biopharmaceuticals Ltd XTLBY CEO 2007-08-21 20,101 0    Premium*  
            Stemline Therapeutics Inc STML Director 2020-06-10 0 0    Premium*  
            Beyond Air Ord Shs XAIR Director 2023-03-20 144,736 0    Premium*  
            Nuvectis Pharma, Inc. NVCT Chairman & CEO, Direct... 2024-05-14 3,246,424 2022-02-04 0    Premium*  
* Premium Members only  

Records found :    152         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-05-12 4 B $14.88 $208,047 D/D 12,245 2,957,704 3.23 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-05-13 4 B $18.10 $12,670 D/D 700 2,958,404 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-05-16 4 B $19.32 $19,320 D/D 1,000 2,959,404 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-05-17 4 B $19.77 $6,245 D/D 310 2,959,714 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-05-18 4 B $18.49 $32,910 D/D 1,700 2,961,414 3.23 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-05-19 4 B $18.95 $3,790 D/D 200 2,961,614 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-05-20 4 B $16.28 $16,280 D/D 1,000 2,962,614 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-05-26 4 B $15.90 $7,950 D/D 500 2,963,114 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-05-27 4 B $15.74 $7,870 D/D 500 2,963,614 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-06-22 4 B $13.10 $1,310 D/D 100 2,963,714 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-06-23 4 B $11.40 $2,280 D/D 200 2,963,914 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-06-24 4 B $12.18 $4,872 D/D 400 2,964,314 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-06-28 4 B $11.82 $3,546 D/D 300 2,964,614 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-06-29 4 B $11.62 $42,994 D/D 3,700 2,968,314 3.23 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-08-11 4 B $8.40 $165,220 D/D 19,669 2,987,983 3.23 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-08-18 4 B $8.58 $123,775 D/D 14,426 3,002,409 3.23 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-08-19 4 B $8.99 $44,950 D/D 5,000 3,007,409 3.23 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-08-23 4 B $9.00 $4,500 D/D 500 3,007,909 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-08-29 4 B $9.07 $9,070 D/D 1,000 3,008,909 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-09-01 4 B $8.11 $4,055 D/D 500 3,009,409 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-09-02 4 B $8.37 $10,044 D/D 1,200 3,010,609 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-09-23 4 B $7.93 $7,930 D/D 1,000 3,011,609 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-09-26 4 B $7.69 $3,845 D/D 500 3,012,109 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-09-28 4 B $7.23 $3,615 D/D 500 3,012,609 3.15 -
NVCT Nuvectis Pharma, Inc. Chairman & CEO   •       •       •   2022-09-30 4 B $7.46 $3,730 D/D 500 3,013,109 3.15 -
  152  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us